Korean J Med.  2000 Oct;59(4):413-422.

Mantle cell lymphoma presented as multiple lymphomatous polyposis: clinical review of 4 cases

Affiliations
  • 1Department of Internal Medicine, Kyungpook National University, School of Medicine, Taegu, Korea.
  • 2Department of Clinical Pathology, Kyungpook National University, School of Medicine, Taegu, Korea.
  • 3Department of Pathology, Kyungpook National University, School of Medicine, Taegu, Korea.
  • 4Cancer Research Institute, Kyungpook National University, School of Medicine, Taegu, Korea.

Abstract

Multiple lymphomatous polyposis(MLP) is an interesting clinical entity of non-Hodgkin's lymphoma(NHL) and is defined as B-cell lymphoma characterized by the presence of multiple lymphomatous polyps along the gastrointestinal tract. Recently MLP has been considered as a variant form of mantle cell lymphoma(MCL). The median survival of patients with MCL is only 3 years, and none of the available conventional chemotherapy regimens appears curative. Encouraging results have been reported with high dose chemotherapy with autoSCT and alloSCT for its treatment. We introduce 4 cases of MLP diagnosed as MCL by morphologic and immunologic method. The common clinical findings of these cases were splenomegaly (4/4), multiple intraabdominal lymphadenopathy (4/4), and advanced stage (3/4) at presentation. The overall remission duration was relatively short (5-27 months) and three of four cases relapsed after conventional chemotherapy or autologous stem cell transplant. Our report suggests that MCL presented as MLP is a high risk subgroup of NHL and more aggressive approach may be needed for cure.

Keyword

Lymphoma; Mantlee - cell; Multiple lymphomatous polyposis

MeSH Terms

Drug Therapy
Gastrointestinal Tract
Humans
Lymphatic Diseases
Lymphoma
Lymphoma, B-Cell
Lymphoma, Mantle-Cell*
Polyps
Splenomegaly
Stem Cells
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr